NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00828386,Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers,https://clinicaltrials.gov/study/NCT00828386,NPC2006,TERMINATED,"This is a randomized, multicenter, phase III trial comparing induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) followed by concurrent chemoradiotherapy to concurrent chemoradiotherapy alone, in nasopharyngeal cancers staged as T2b, T3, T4 and/or with lymph node involvement (≥ N1. The main end point is the event free survival.",NO,Nasopharyngeal Cancers,PROCEDURE: Induction chemotherapy + concurrent radiochemotherapy vs. concurrent radiochemotherapy,"Event free-survival, 3 years","Survival, 3 years|late and acute toxicity according to NCI-CTC and EORTC/RTOG criteria, early and late|Cumulative incidence of loco-regional progression, 3 years|Cumulative rate of metastasis, 3 years|Global response to chemo-radiotherapy, 3 years|Global response to induction chemotherapy, after the induction chemotherapy of the last patient included",,Groupe Oncologie Radiotherapie Tete et Cou,,ALL,"ADULT, OLDER_ADULT",PHASE3,83,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,GORTEC NPC2006,2009-01,2017-04-19,2017-04-19,2009-01-23,,2019-01-18,"Hôpital de la Pitié-Salpétrière, Paris, 75013, France|Institut Gustave Roussy, Villejuif, 94805, France|University of Casablanca, Casablanca, Morocco|University of Cluj, Cluj, Romania|Hôpital Habib Bourguiba, Sfax, Tunisia",
